- Home
- MBLY vs MANE Comparison
MBLY vs MANE Comparison
Compare MBLY & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBLY | MANE |
|---|---|---|
| Founded | 1999 | 2019 |
| Country | Israel | United States |
| Employees | 4200 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MBLY | MANE |
|---|---|---|
| Price | $8.23 | $111.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 4 |
| Target Price | $14.13 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 8.7M | 572.2K |
| Earning Date | 04-23-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,894,000,000.00 | N/A |
| Revenue This Year | $4.91 | N/A |
| Revenue Next Year | $13.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.51 | N/A |
| 52 Week Low | $6.47 | $36.26 |
| 52 Week High | $15.81 | $131.24 |
Technical Indicators
Market Signals| Indicator | MBLY | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 42.81 | 49.86 |
| Support Level | $7.66 | $104.45 |
| Resistance Level | $10.01 | $112.83 |
| Average True Range (ATR) | 0.59 | 9.51 |
| MACD | -0.15 | -1.15 |
| Stochastic Oscillator | 35.04 | 26.51 |
Price Performance
Historical ComparisonAbout MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Moovit. The solutions provided by the company are: Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.